← All stocks

Climb Bio, Inc.

CLYM Net buying

CIK 0001768446 #2557 in the set updated 19 Sep 2026

Bought (120 mo)

$100.73M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$6.15M

$2.69M on a plan · $0.00 straight out of an exercise

Sold at will

$3.46M

15 of 27 sales

Net

+$94.58M

+$97.28M against sales at will

By person

6 insiders · 41 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

RA CAPITAL MANAGEMENT, L.P. entity

Director

$90.73M (7)

—

+$90.73M

4,244,516

7.39%

$58.01M

—

AI ETI LLC entity

10% owner

$10.00M (1)

—

+$10.00M

5,009,400

8.72%

$68.47M

—

Morisset Valerie

EVP, R&D AND CSO

—

$3.45M (14)

−$3.45M

31,317

0.0545%

$428.05K

−79.2%

Thomas Stephen Basil

Director

—

$2.25M (5) scheduled

−$2.25M

467,969

0.8148%

$6.40M

+13.2%

Brennan Aoife

President and CEO

—

$432.13K (2) scheduled

−$432.13K

87,731

0.1527%

$1.20M

+4,910%

Pimblett Emily

SVP, Finance & CAO

—

$24.33K (6) scheduled

−$24.33K

18,888

0.0329%

$258.16K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 95

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 13

Sales on a Rule 10b5-1 plan 12

Sales straight out of an exercise 0

Sales at will 15

Transactions with no price 0

Shares from compensation/vesting 37,606,580

History held since 11 Aug 2021